Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

por Chen, Yen-Ju, Tsai, Chin-Yi, Cheng, Ying-Min, Nieh, Su-Wen, Yeh, Teng-Kuang, Chen, Ching- Ping, Wang, Min-Hsien, Chou, Ling-Hui, Chiu, Tai-Yu, Liu, Li, Ho, Chien, Chen, Chiung- Tong, Liu, Tsang-Wu
Publicado 2020

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer

por Lin, Wen-Hsing, Yeh, Teng-Kuang, Jiaang, Weir-Torn, Yen, Kuei-Jung, Chen, Chun-Hwa, Huang, Chin-Ting, Yen, Shih-Chieh, Hsieh, Shu-Yi, Chou, Ling-Hui, Chen, Ching-Ping, Chiu, Chun-Hsien, Kao, Li-Chun, Chao, Yu-Sheng, Chen, Chiung-Tong, Hsu, John T.-A.
Publicado 2014

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

por Chen, Yun-Yu, Lo, Chen-Fu, Chiu, Tai-Yu, Hsu, Chia-Yu, Yeh, Teng-Kuang, Chen, Ching-Ping, Huang, Chen-Lung, Huang, Chung-Yu, Wang, Min-Hsien, Huang, Yu-Chen, Ho, Hsuan-Hui, Chao, Yu-Sheng, Shih, Joe C., Tsou, Lun K., Chen, Chiung-Tong
Publicado 2020

Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer

por Li, Mu-Chun, Coumar, Mohane Selvaraj, Lin, Shu-Yu, Lin, Yih-Shyan, Huang, Guan-Lin, Chen, Chun-Hwa, Lien, Tzu-Wen, Wu, Yi-Wen, Chen, Yen-Ting, Chen, Ching-Ping, Huang, Yu-Chen, Yeh, Kai-Chia, Yang, Chen-Ming, Kalita, Bikashita, Pan, Shiow-Lin, Hsu, Tsu-An, Yeh, Teng-Kuang, Chen, Chiung-Tong, Hsieh, Hsing-Pang
Publicado 2023

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins

por Chi, Ya-Hui, Yeh, Teng-Kuang, Ke, Yi-Yu, Lin, Wen-Hsing, Tsai, Chia-Hua, Wang, Wan-Ping, Chen, Yen-Ting, Su, Yu-Chieh, Wang, Pei-Chen, Chen, Yan-Fu, Wu, Zhong-Wei, Yeh, Jen-Yu, Hung, Ming-Chun, Wu, Mine-Hsine, Wang, Jing-Ya, Chen, Ching-Ping, Song, Jen-Shin, Shih, Chuan, Chen, Chiung-Tong, Chang, Chun-Ping
Publicado 2021

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation

por Hsu, Yung Chang, Coumar, Mohane Selvaraj, Wang, Wen-Chieh, Shiao, Hui-Yi, Ke, Yi-Yu, Lin, Wen-Hsing, Kuo, Ching-Chuan, Chang, Chun-Wei, Kuo, Fu-Ming, Chen, Pei-Yi, Wang, Sing-Yi, Li, An-Siou, Chen, Chun-Hwa, Kuo, Po-Chu, Chen, Ching-Ping, Wu, Ming-Hsine, Huang, Chen-Lung, Yen, Kuei-Jung, Chang, Yun-I, Hsu, John T.-A., Chen, Chiung-Tong, Yeh, Teng-Kuang, Song, Jen-Shin
Publicado 2016